Another founding member, the New York Genome Center, is an independent, non-profit organization leveraging the collaborative resources of leading academic medical centers, research universities, and commercial organizations to create one of the largest genomics research facilities in North America. As an enterprise focused squarely on fostering a collaborative environment, it believes its involvement in the network will help drive the translation of basic research into clinical care.
“The New York Genome Center has brought together leading research, clinical, and technology collaborators in an effort to transform science and healthcare,” said Nancy J. Kelley, NYGC Founding Executive Director. “Partners HealthCare and Illumina share our vision for innovation through collaboration, so we are privileged to be a Founding Member of the GeneInsight-Illumina Network. We look forward to using these new tools with other members of the network to promote discovery and improve patient care.”
In September 2012, Partners HealthCare and Illumina announced their strategic alliance and shared commitment to bringing a broader community of clinical laboratories together to expand and enrich collective knowledge about genetics with the goal of improving patient care.
“Today’s announcement represents a significant milestone toward achieving GeneInsight and Illumina’s shared vision of enabling the market to apply sequencing technology to improve human health. Illumina is excited to be among such reputable founding members and is committed to using GeneInsight in our CLIA-certified, CAP accredited laboratory to support the growing demand for our Understand Your Genome Symposia,” said Matt Posard, Senior Vice President and General Manager of Illumina’s Translational and Consumer business.About Partners HealthCare Partners HealthCare is a Boston-based integrated health system founded by Brigham and Women’s Hospital and Massachusetts General Hospital that also includes community and specialty hospitals, community health centers, a physician network, and home health and long-term care services. Further information can be found by visiting www.partners.org. About GeneInsight, LLC GeneInsight LLC ( www.geneinsight.com) is a wholly-owned subsidiary of Partners HealthCare. GeneInsight Suite® was developed by Partners HealthCare in collaboration with leading geneticists, laboratory operations personnel, practicing physicians and IT professionals. GeneInsight has been in clinical use since 2005 and has supported the interpretation and reporting workflow for more than 25,000 complex genetic tests across multiple diagnostic reference laboratories, including Partners HealthCare Laboratory for Molecular Medicine. About Illumina Illumina ( www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare. Forward-Looking Statements This release may contain forward looking statements that involve risks and uncertainties. Important factors that could cause actual results to differ materially from those in any forward-looking statements are detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. We do not intend to update any forward-looking statements after the date of this release.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts